Filter
1388
Filtered Results: 1388
Text search:
Antimicrobial
resistance
Featured
Recommendations
158
New Publications
278
Language
Document type
No document type
389
Studies & Reports
338
Guidelines
279
Strategic & Response Plan
99
Fact sheets
84
Manuals
76
Online Courses
30
Training Material
22
Resource Platforms
19
Videos
16
Situation Updates
13
Infographics
13
Brochures
9
Dashboards/Maps
1
Countries / Regions
Global
65
India
48
South Africa
36
Kenya
35
Africa
33
Ethiopia
28
Western and Central Europe
27
Latin America and the Carribbean
23
Nigeria
16
Nepal
14
Sierra Leone
13
Ghana
12
Uganda
12
Tanzania
11
South–East Asia Region
11
Malawi
10
Asia
10
Western Pacific Region
9
Eastern Europe
9
Russia
9
Bangladesh
8
Liberia
8
Rwanda
7
Cameroon
7
Zimbabwe
7
Philippines
7
Eastern Europe and Central Asia
7
Indonesia
7
Ukraine
6
Zambia
6
Germany
5
West and Central Africa
5
East and Southern Africa
5
Myanmar / Burma
5
Colombia
4
Senegal
4
Burkina Faso
4
Vietnam
4
Namibia
4
Tajikistan
3
Thailand
3
Lesotho
3
China
3
Peru
3
Haiti
3
Cambodia
3
Uruguay
3
Argentina
3
Mali
3
South Sudan
3
Eswatini/ Swaziland
3
North Macedonia
2
Serbia
2
Chile
2
Syria
2
Laos
2
Mozambique
2
Jordan
2
Congo, Democratic Republic of
2
Middle East and North Africa
2
Gabon
2
France
2
Bolivia
2
Brazil
2
Georgia
2
Madagascar
2
Pakistan
2
Timor Leste/ East Timor
1
Mexico
1
El Salvador
1
Benin
1
Kazakhstan
1
Iran
1
Albania
1
Fiji
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Afghanistan
1
Morocco
1
Qatar
1
Guinea
1
Armenia
1
USA
1
Guinea-Bissau
1
Venezuela
1
Ireland
1
Saudi Arabia
1
Paraguay
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
United Kingdom
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Nicaragua
1
Sri Lanka
1
Egypt
1
Sudan
1
Yemen
1
Honduras
1
Angola
1
Libya
1
Bhutan
1
Botswana
1
Iraq
1
Somalia
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
334
Clinical Guidelines
96
Key Resources
92
Public Health
53
Women & Child Health
42
Pharmacy & Technologies
22
Capacity Building
19
Annual Report MEDBOX
3
Toolboxes
AMR
555
TB
90
Planetary Health
87
COVID-19
72
Rapid Response
59
HIV
58
Pharmacy
53
Caregiver
48
NTDs
38
Global Health Education
35
Health Financing Toolbox
27
Cholera
20
Ebola & Marburg
18
Refugee
16
Mental Health
9
NCDs
8
Conflict
8
Natural Hazards
5
Polio
3
Specific Hazards
1
Disability
1
Social Ethics
1
Zika
1
The WHO Cholera Vaccine Position Paper (August 2017) highlights the importance of oral cholera vaccines (OCVs) as a key tool in outbreak response and prevention, alongside water, sanitation, and hygiene (WASH) measures. It recommends OCVs for high-risk populations, endemic areas, and humanitarian cr...
Prevention, identification and management of health worker infection in the context of COVID-19
recommended
This document provides interim guidance on the prevention, identification and management of health worker infection in the context of COVID-19. It is intended for occupational health departments, infection prevention and control departments or focal points, health facility administrators and public ...
This Pharmaceutical Country Profile for Kenya (2010) has been developed by the Ministry of Medical Services with support of the World Health Organization. The Profile contains information on existing socio-economic and health-related conditions, resources, regulatory structures and processes and out...
Traditional food markets play important economic, cultural, and social role and are sources of livelihood for millions of people in urban and rural areas. The manual Five keys for safer traditional food markets: risk mitigation in traditional food markets in the Asia-Pacific Region aims to support a...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
Strategic communication is at the heart of public health and more important than ever in the digital age. Using communication strategically requires expertise, skills and resources to plan, implement and evaluate interventions that encourage governments to implement policies that improve people’s ...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
To meet our Strategy objectives and get within reach
of the 2030 SDG 3 target related to the three diseases,
the Global Fund needs to raise US$18 billion for the
Eighth Replenishment. That sum is essential to drive the
required pace of progress in the fight against HIV, TB
and malaria, and to m...
To deliver on the Global Fund Strategy milestones
for 2028 and ensure we keep the SDG 3 target
within reach, we need to raise US$18 billion to
fund the Global Fund’s next three-year grant cycle.
The Council was established in late 2020 by Dr Tedros Adhanom
Ghebreyesus (Director-General, WHO) to provide new economic thinking – reassessing how health and wellbeing are valued, produced and distributed across the economy. An all-female group of 10 distinguished economists and area experts, t...
There has never been a more critical moment to invest in WHO, and strengthen the unique role it plays in global health. Now is the time to sustainably finance WHO and invest in a healthy return for all.
Skin-related neglected tropical diseases, or “skin NTDs”, are historically neglected because active case detection, individual case management, significant resources and intensive effort are required to control, eliminate and eradicate them. Integrated control and management of skin NTDs offers ...
